{
    "doi": "https://doi.org/10.1182/blood.V130.Suppl_1.5527.5527",
    "article_title": "Superiority of Triple Combination Bortezomib + Cyclophosphamide and Dexamethasone (VCD) Versus Thalidomide + Cyclophosphamide and Dexamethasone (CTD) in Newly Diagnosed Multiple Myeloma Transplant-Eligible Patients ",
    "article_date": "December 7, 2017",
    "session_type": "731. Clinical Autologous Transplantation: Results",
    "abstract_text": "Background- The treatment of multiple myeloma has evolved significantly in the last decade and combinations of the new drugs have allowed better responses and significant gain in survival. Studies comparing different chemotherapy combinations before transplant suggest that the triple combo is superior to double. The use of bortezomib as backbone in these combos has been identified as superior to other drugs. Unfortunately bortezomib is not part of the drugs available for use in the Brazilian public health system to myeloma treatment and the only available drug is thalidomide. Comparisons between different triple combinations are rare in the literature. In the present study we compared two different triple combinations composed of bortezomib + cyclophosphamide + dexamethasone (VCD) versus thalidomide + cyclophosphamide + dexamethasone (CTD) in order to identify which of the two combinations lead to the best response after 4 cycles before bone marrow transplantation for eligible new diagnose patients with multiple myeloma. Methods- The patients that were submitted to induction treatment with VCD or CTD protocol between June 2009 and June 2014 had been included retrospectively from 24 different centers. The primary endpoint was very good partial response (VGPR) rate or better following 4 cycles. Response was re-assessed in a central evaluation according to the IMWG criteria. Results- A total of 311 patients were included from 24 centers, of which eight are private and the others 16 were public/philanthropic. The VCD combination was used as induction by 117 (37.6%) patients, and 194 (62.4%) patients performed the CTD scheme. After four cycles of induction, we identified as a intention to treat base that better than very good partial response was 54% for the VCD group versus 42.8% for the CTD group (p = 0.05). Regarding toxicity two alterations were evaluated: Neuropathy was reported in 114 cases, 46 in the VCD group (39.3%) and 68 in the CTD group (35.1%) and grade > 3 of neuropathy represent 10% and 7% respectively. There was no statistically difference between the two groups (p = 0.526). And thrombosis was reported in only 14 cases (four patients treated with VCD and 10 with CTD), without significant difference. Conclusion- This is the first multicentric analysis between two main treatments used in Brazilian centers as induction for eligible multiple myeloma patients. VCD showed significant superiority to CTD in terms of VGPR or better. Neuropathy rates low in both groups. Our finds reinforce the need to make bortezomib available as a treatment option for all patients with multiple myeloma in Brazil. Disclosures De Queiroz Crusoe: Janssen, Celgene, Amgen, Takeda: Honoraria. Bittencourt: Janssen, Takeda: Honoraria. Maiolino: Janssen, Takeda, Amgen, Celgene, Sanofi, Teva, Bristol,Novartis: Honoraria. Ribeiro: Janssen,: Honoraria. Leao: Janssen: Honoraria. Pinto Neto: Janssen, Takeda: Honoraria. Laks: Janssen: Honoraria. Magalh\u00e3es: Janssen: Honoraria. Hungria: Celgene, Roche, Takeda, Janssen, Amgen: Honoraria.",
    "topics": [
        "bortezomib",
        "cyclophosphamide",
        "dexamethasone",
        "multiple myeloma",
        "thalidomide",
        "transplantation",
        "vocal cord dysfunction",
        "neuropathy",
        "partial response",
        "bone marrow transplantation"
    ],
    "author_names": [
        "Edvan De Queiroz Crusoe",
        "Fabiana Higashi, MD",
        "Gracia Martinez, MD",
        "Rosane Bittencourt, MD",
        "Angelo Maiolino, MD",
        "Lais Sousa, MD",
        "Renata Ferreira Marques Nunes, MD",
        "Glaciano Ribeiro, MD",
        "Jandir Nicacio, MD",
        "Karla Richter Zanella, MD",
        "Andre Magalhaes, MD",
        "Danielle Leao, MD",
        "Jorge Vaz Pinto Neto, MD",
        "Abrah\u00e3o Elias Hallack Neto, MD PhD",
        "Walter Braga, MD",
        "Emmanuella G Souza, MD",
        "Antonio Julio A.M. Guimaraes, MD",
        "Giovanna Steffenello Durigon, MD",
        "Dani Laks, MD PhD",
        "Jose Mauro Kutner, MD PhD",
        "Gilberto Colli, MD",
        "Rodrigo Santucci, MD",
        "Roberto Jos\u00e9 Pessoa Magalh\u00e3es, MD",
        "Vania T M Hungria, MD PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Edvan De Queiroz Crusoe",
            "author_affiliations": [
                "Rua Dra Doutro Vianna S/n, Universidade Federal da Bahia- Hospital Universitario, Salvador, Brazil "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Fabiana Higashi, MD",
            "author_affiliations": [
                "Santa Casa De Sao Paulo, Sao Paulo, BRA "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gracia Martinez, MD",
            "author_affiliations": [
                "Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil ",
                "Hematology, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, BRA "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rosane Bittencourt, MD",
            "author_affiliations": [
                "HC Porto Alegre, Porto Alegre, Brazil "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Angelo Maiolino, MD",
            "author_affiliations": [
                "Hospital Universitario Clementino Fraga Filho Universidade Federal do Rio de Jan, Rio de Janeiro, Brazil "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lais Sousa, MD",
            "author_affiliations": [
                "CEHON Clinic, Salvador, Brazil "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Renata Ferreira Marques Nunes, MD",
            "author_affiliations": [
                "Hospital Brigadeiro, Sao Paulo, Brazil "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Glaciano Ribeiro, MD",
            "author_affiliations": [
                "Cl\u00ednica Hematologica, Belo Horizonte - Minas Gerais, Brazil "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jandir Nicacio, MD",
            "author_affiliations": [
                "Hospital de Base- S\u00e3o Jos\u00e9 do Rio Preto- S\u00e3o Paulo, Sao Jose do Rio Preto- SP, Brazil "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Karla Richter Zanella, MD",
            "author_affiliations": [
                "Clinica Viver- CEPHON, Florian\u00f3polis, BRA "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andre Magalhaes, MD",
            "author_affiliations": [
                "Clinica CEHON- Juazeiro, Juazeiro-BA, Brazil "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Danielle Leao, MD",
            "author_affiliations": [
                "Hospital Universitario Universidade Federal de Goiais, Goiais, Brazil "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jorge Vaz Pinto Neto, MD",
            "author_affiliations": [
                "Clinica CETTRO, Brasilia, BRA "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Abrah\u00e3o Elias Hallack Neto, MD PhD",
            "author_affiliations": [
                "Universidade Federal De Juiz De Fora, Juiz de Fora, BRA "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Walter Braga, MD",
            "author_affiliations": [
                "Univsersidade Federal de Sao Paulo- UNIFESP, S\u00e3o Paulo, Brazil "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Emmanuella G Souza, MD",
            "author_affiliations": [
                "Universidade Federal de Minas Gerais- Hospital Universitario, Belo Horizonte- MG, Brazil "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonio Julio A.M. Guimaraes, MD",
            "author_affiliations": [
                "Hemorio, Rio De Janeiro, BRA "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giovanna Steffenello Durigon, MD",
            "author_affiliations": [
                "Universidade Federal De Santa Catarina, Florianopolis, BRA "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Dani Laks, MD PhD",
            "author_affiliations": [
                "Instituto de Hematologia- Porto Alegre, Porto Alegre-RS, Brazil "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose Mauro Kutner, MD PhD",
            "author_affiliations": [
                "Hospital Israelita Albert Einstein, Sao Paulo, BRA "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gilberto Colli, MD",
            "author_affiliations": [
                "Funda\u00e7ao Pio XII Barretos, Barretos, BRA "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rodrigo Santucci, MD",
            "author_affiliations": [
                "HEMOMED, Sao Paulo, BRA "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roberto Jos\u00e9 Pessoa Magalh\u00e3es, MD",
            "author_affiliations": [
                "Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vania T M Hungria, MD PhD",
            "author_affiliations": [
                "Hematology, Clinica S\u00e3o Germano, S\u00e3o Paulo, Brazil ",
                "Hematology, Santa Casa Medical School, S\u00e3o Paulo, Brazil"
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-12T02:39:22",
    "is_scraped": "1"
}